Diabetes Mellitus in Children and Adolescents with Genetic Syndromes
diabetes compared to children with type 1 DM (T1DM) (18.9 % (DS) vs. 6.4 % (T1DM)) [ 1 ] . Forbes and Engel were the fi rst to report the increased incidence of DM in 41 patients with "gonadal dysgenesis" [ 13 ] . The incidence of T1DM in Danish patients with TS was 11 times higher and the incidence of type 2 DM (T2DM) was 3-4 times higher than in healthy girls [ 2 , 14 ] . However, according to a recent report, young normal-weight women with TS had signifi cant glucose intolerance in spite of normal insulin secretion during hyperglycaemic clamp and normal insulin sensitivity [ 3 ] . These authors suggested that the data could be interpreted as a syndrome specifi c background for the development of diabetes. In contrast to many publications which subclassify genetic syndrome-associated diabetes as T1DM or T2DM, we used the WHO classifi cation for these forms of diabetes, which is "other genetic syndromes sometimes associated Introduction ▼ Diabetes mellitus (DM) in childhood, adolescence and adulthood is well known to be associated with certain genetic conditions such as Down syndrome (DS) [ 1 ] , Turner syndrome (TS) [ 2 , 3 ] , Prader-Willi syndrome (PWS) [ 4 , 5 ] , Friedreich ataxia (FA) ( [ 6 ] , Klinefelter syndrome (KS) [ 7 , 8 ] , Bardet-Biedl syndrome (BBS) [ 9 ] , Alström syndrome (AS) [ 10 ] and Berardinelli-Seip syndrome (BSS), also known as congenital generalised lipodystrophy [ 11 ] . However, epidemiological data are scant. Diabetes occurs more frequently in individuals with DS than in those without DS. A study from Denmark, for instance, reported that the prevalence of diabetes was 4.2 times higher in DS patients than in the general population [ 12 ] . Moreover, diabetes onset during the fi rst 3 years of life is more frequent in children with DS and mean age, age at diabetes onset, daily insulin dose, HbA 1c , micro-and macroalbuminuria, retinopathy and dyslipidaemia. Descriptive statistics and standard statistical tests were used for data analysis. Results: In total, 205 DM patients had one of the following syndromes: DS (141 patients), TS (24) , PWS (23) , FA (5), AS (5), KS (4), BBS (2) and BSS (1) . Diabetes-specifi c antibodies were positive in the majority of patients with DS, TS and FA. Conclusion: Despite the well-known association between DM and certain syndromic disorders, the number of aff ected patients in the German and Austrian paediatric diabetic population is very low. Nevertheless, physicians should be aware of syndromic forms of diabetes. Joint multicentre analyses are needed to draw relevant conclusions.
diabetes" within the third subgroup of "other specifi c types" of diabetes [ 15 ] . A higher incidence of DM was found in men with KS [ 7 ] . This led to the hypothesis that DM in adults might be favoured by alterations of the sex chromosomes [ 16 ] . PWS patients are often severely obese. PWS is caused by a deletion or disruption of one or several genes on the proximal long arm of the paternal chromosome 15. Maternal disomy 15 is another possible cause of this syndrome [ 17 ] . In PWS, elevated plasma ghrelin levels contribute to hyperphagia and obesity [ 18 ] . Nevertheless, ghrelin levels were reported to be negatively correlated with fasting insulin and the homeostasis model assessment insulin resistance index (HOMA-IR) [ 19 ] . DM and cardiomyopathy are among the non-neurological characteristics of FA [ 6 ] , a disorder caused by mutations in the frataxin gene on chromosome 9q [ 20 ] . Hyperinsulinism and DM have also been reported to be associated with AS, another autosomal recessive genetic disorder in which the gene defect is located on chromosome 2p13. These patients develop retinitis pigmentosa, which leads to blindness. In addition, hearing loss and obesity have been reported in connection with AS and dilated cardiomyopathy is found in about 70 % of AS patients. Other clinical manifestations of AS include renal, pulmonary and liver failure as well as urological dysfunction [ 21 ] . Multimorbidity is also found in BBS, a disorder with autosomal recessive inheritance. Apart from retinitis pigmentosa and hearing loss, patients with BBS -in contrast to those with ASpresent with mental retardation and polydactyly. In 1954 and 1959, Berardinelli and Seip, respectively, described a form of congenital lipodystrophy. BSS is an inherited autosomal-recessive disorder characterised by the absence of subcutaneous adipose tissue from birth or early childhood in conjunction with insulin resistance [ 22 , 23 ] . The gene defect is located on chromosome 11q13 [ 24 ] . In these patients, DM is characterised by massive hepatic insulin resistance and requires high doses of insulin. Due to lack of fatty tissue, functional leptin defi ciency aggravates the insulin resistance. Treatment with subcutaneous leptin can improve all clinical abnormalities including diabetes [ 25 ] . For completeness, the present study includes data on 141 patients with DS. A more detailed analysis of DPV data on 159 paediatric diabetes patients with DS has recently been published [ 1 ] .
Patients and Methods

▼
DPV design
Created in 1990, the DPV ("Diabetes-Patienten-Verlaufsdaten") database prospectively collects longitudinal, anonymised follow-up data on children and adolescents with DM in a standardised manner using customised software developed at the University of Ulm, Ulm, Germany, based on Microsoft Visual FoxPro 9.2 (Microsoft Corporation, Redmond WA, USA) [ 26 ] . The DPV software was used to collect relevant longitudinal data, including anthropometric parameters, diagnosis, type of diabetes, current age, age at diabetes onset, daily insulin dose, diabetes-specifi c antibodies, body mass index (BMI) and glycated haemoglobin (HbA 1c ).
Patients
Eligible for inclusion in the present analysis were all patients with DS [ 1 ] , TS, PWS, FA, AS, KS, BBS or BSS out of all patients with DM onset under the age of 20 years who were registered with the DPV database as of March 2010. Data were collected from 309 treatment centres in Germany and Austria. Children from an immigrant background were defi ned as those with at least one parent not born in Germany or Austria.
Ethics approval
Analysis of anonymised routine data within the DPV initiative was approved by the Ethics Committee of the Medical Faculty of the University of Ulm.
Antibodies
The following diabetes-specifi c antibodies were studied: GAD antibodies (glutamic acid decarboxylase antibodies), IAA (insulin autoantibodies), ICA (islet cell antibodies), IA2 (antibodies against a protein tyrosine phosphatase-like protein). IAA were included only if measured prior to insulin therapy. All antibody determinations were performed in accredited laboratories participating in the Diabetes Antibody Standardisation Programme, which included workshops with sample exchange and crossvalidation [ 27 ] . Furthermore, thyroid-specifi c antibodies (anti-thyroid peroxidase antibodies and anti-thyroglobulin antibodies) as well as coeliac disease-specifi c antibodies (e. g. gliadin IgA, gliadin IgG antibodies and transglutaminase IgA antibodies) were documented by the participating centres [ 28 ] .
Lipid parameters
Total cholesterol, HDL and LDL cholesterol as well as triglyceride levels were determined at each treatment centre using commercially available kits. Dyslipidaemia was defi ned in accordance with international standards using the following cut-off values: total cholesterol > 5.6 mmol/l ( > 230 mg/dl); HDL cholesterol < 0.9 mmol/l ( < 35 mg/dl); LDL cholesterol > 4.6 mmol/l ( > 160 mg/dl); triglycerides > 1.7 mmol/l ( > 130 mg/dl) [ 29 ] .
Blood Pressure
Arterial hypertension was defi ned as a blood pressure above the 95 th percentile according to the American Heart Association's normal values for children and adolescents [ 30 ] .
Metabolic control
HbA 1c measurements for long-term glycaemic control from different laboratories were mathematically standardised to the DCCT (Diabetes Control and Complications Trial) reference range of 4.05-6.05 % using the MOM method [ 31 , 32 ] .
Anthropometric parameters
The defi nitions of overweight and obesity in children and adolescents were based on the BMI (kg/m 2 ). BMI values above the 90 th and 97 th percentiles for age and sex were defi ned as overweight and obesity, respectively. Comparisons of BMI values adjusted for age and sex were performed using the BMI standard deviation scores (BMI-SDSs) [ 33 ] . Published normative BMI data recommended for German children were used [ 34 ] . 
Treatment modalities
Treatment modality was evaluated as insulin therapy only, oral anti-diabetic drugs (such as biguanides, sulphonylureas, acarbose, or glinides) alone or in combination with insulin, or nonpharmacological treatment with lifestyle modifi cations only. The insulin regime was documented as the number of daily injections, insulin dose, and the use of human insulin vs. either long-acting or rapid-acting insulin analogues.
Statistical analysis
Data analysis was performed using the statistical software package SAS, version 9.2 (SAS Institute Inc., Cary, NC, USA). Results for continuous parameters were expressed as mean ± standard deviation (SD). The Kruskal-Wallis and Chi-square tests were used for non-parametric statistics and binary variables, respectively. The Bonferroni step-down method was used to correct for multiple comparisons. Values of p < 0.05 were considered statistically signifi cant.
Results
▼
In total, 43 521 patients with DM were included in the present analysis. 39 622 patients had T1DM and 684 patients had T2DM. The genetic syndromes investigated in this study were present in 205 patients (including 141 patients with DS [ 1 ] ). Other specifi c forms of diabetes, including MODY, cystic-fi brosis-related diabetes or neonatal diabetes were present in 3 010 patients, who were not included in this analysis.
• ▶ Table 1 shows the prevalence and clinical characteristics of each syndrome, including antibody results.
• ▶ Table 4 ).
The third largest group with a syndromic form of DM comprised 23 patients with PWS. Out of 10 patients tested for beta-cell antibodies, 4 (40 %) were found to be positive. 8 patients received insulin therapy (mean daily insulin dose: 0.53 IU/day). In addition, 8 patients were treated with oral antidiabetic agents (biguanides in 6 patients, sulphonylureas in 2 patients and insulin sensitizers in 3 patients). The other patients received no pharmacological treatment. None of the DPV-registered PWS patients was treated with GH. We found no signifi cant diff erence between PWS patients with and those without beta-cell antibodies regarding treatment, complications or age at onset of diabetes. There was a marked, but not statistically signifi cant, diff erence in metabolic control (HbA 1c was 8.3 % in patients with beta-cell antibodies and 6.4 % in patients without beta-cell antibodies, p = 0.088). There were 5 patients (2 boys and 3 girls) with FA in the database. Out of 3 patients tested for beta-cell antibodies, 2 (66.7 %) had a positive result. All FA patients were treated with insulin (1.08 IU/kg). Out of 5 patients (2 boys and 3 girls) with AS, 2 were tested for beta cell antibodies, 1 of them with a positive result. 3 of the 5 AS patients were treated with biguanides. No AS patient received insulin therapy. In the other 2 patients diabetes treatment consisted of lifestyle modifi cation only. Triglyceride determinations were documented for 2 patients and, as expected, triglyceride levels were elevated in both patients. For 2 of 4 patients with KS, diabetes specifi c beta-cell antibodies were documented, with IAA being positive in 1 patient. 1 patient was treated with insulin ( ≥ 4 injections/day; insulin dose: 1.13 IU/kg/day), 1 patient received biguanides, and 2 patients received no pharmacological treatment. DM was associated with BBS in 2 patients (1 boy and 1 girl). The girl developed DM at age 2.8 years. Beta-cell antibodies were found to be positive. She received an insulin dose of 0.76 IU/kg/ day. The boy was 15 years old at the onset of DM and also received insulin, but at a lower dose of 0.16 IU/kg/day, divided into 2 daily injections. He was tested negative for beta-cell antibodies. The only patient with BSS, a girl, did not receive insulin but had instead been given metformin since puberty, in addition to leptin therapy. Antibody determinations were not performed. A recent DPV publication reported an analysis of 159 cases of diabetes in patients with DS, including some older patients [ 1 ] . This analysis confi rms a higher prevalence of diabetes in DS compared to the general population. The distribution of age at onset showed a shift towards a younger age in DS. The data of Rohrer et al. [ 1 ] confi rm that coeliac disease and thyroid antibodies are more prevalent in DS. The high rate of positive betacell antibodies supports an autoimmune aetiology of diabetes in DS patients. A Danish study reported that 18 of 798 women with TS had T1DM [ 35 ] . A prospective study by Bakalov et al. examined the Table 3 Autoimmune antibodies in patients with Turner syndrome (TS). prevalence of diabetes in adult participants in an intramural National Institutes of Health (NIH) TS study. T2DM was found in 56 of 224 (25 %), and T1DM was present in 1 woman ( < 0.5 %) [ 36 ] . In contrast to these publications, we used the WHO classifi cation of these forms of diabetes as "other genetic syndromes sometimes associated with diabetes" within the third subgroup of "other specifi c types" of diabetes [ 15 ] . A comparison of our data with the data on American or Danish DM patients with TS is diffi cult due to diff erences in data analysis. Whereas Jørgensen et al. [ 35 ] and Bakalov et al. [ 36 ] described the frequency of diabetes in the population of all TS patients, we analysed the frequency of TS in the diabetes population. All studies reported a higher incidence of diabetes in girls or women with TS, which was also the second largest group of patients with a syndromic form of diabetes in our study.
Discussion and Conclusion
Auto-antibodies
In the French National PWS paediatric database 74 of 142 children aged 0.2-18.8 years were evaluated for DM. Only 4 % showed glucose intolerance without having diabetes [ 37 ] . In a group of 50 obese Italian children and adolescents with PWS, there were 4 patients with DM [ 5 ] . The prevalence of diabetes in our PWS patients was higher than in the Italian or French patients. This may be due to the fact that almost all German and Austrian children with DM are registered in the DPV database. According to data from the Danish Cytogenetic Central Register there were 49 patients with diabetes among 859 males diagnosed with KS [ 38 ] . The higher number of diabetic KS patients in the Danish publication may be explained by the large study population, as the Danish Cytogenetic Central Register covers all patients with KS whereas the DPV database includes only KS patients under the age of 20 years. As regards AS, BBS and BSS, no data on the prevalence of diabetes in these syndromes were found in the literature. The higher proportion of immigrant background amongst patients with syndromic forms of diabetes compared to T1DM or T2DM may be due to consanguinity in certain syndromes, e. g. AS, PWS and BBS. Ethnic infl uences as seen in T2DM patients also need to be discussed. AS, PWS, and BBS are associated with obesity and metabolic syndrome. Among diabetic patients with TS the proportion of immigrant background was not found to be increased.
In our study population, the BMI-SDS for T1DM was lower than for T2DM and syndromic forms of diabetes. The group of diabetic patients with AS, PWS and BBS had a higher BMI-SDS. This is not unexpected as obesity is typically associated with these syndromes. Hypertension was found in 10.6 % of all T1DM patients compared to 29.5 % in T2DM and was even more frequent in patients with PWS (25 %), KS (50 %), BBS (50 %) or BSS (100 %). A possible explanation is a concomitant metabolic syndrome in these entities. An increased rate of hypertension compared with T1DM was detected in all groups with a mean HbA 1c above 7.0 %. This was similar to the rate of dyslipidaemia. As regards BMI-SDS, there was a detectable association with the hypertension ratio (T1DM: BMI-SDS 0.53, hypertension 10.60 %; syndromic forms of diabetes: BMI-SDS for all these patients 1.21, hypertension 10.60 %; T2DM: BMI-SDS 2.33, hypertension 29.50 %). Most of the syndromic forms of diabetes (except DS, FA and BSS) showed a higher rate of microalbuminuria than T1DM or T2DM. However, the rate of macroalbuminuria was found to be increased only in PWS. Nephropathy unrelated to diabetes is not known to be a typical feature of PWS. In PWS, the combination of high BMI with high rates of dyslipidaemia and hypertension could lead to elevated albumin excretion. In 1997, rapidly progressive diabetic retinopathy and nephropathy were described in a white man with PWS [ 39 ] . The reason for the lower rate of retinopathy in our PWS population might be explained by the low number of patients tested for retinopathy (only 5 out of 23), or low sensitivity of ophthalmoscopy when performed by inexperienced ophthalmologists. Similar to macroalbuminuria (except PWS), the retinopathy ratio was negative. The higher rate of microalbuminuria compared to retinopathy in syndromic forms of diabetes may be due to multisystem disorders. In most syndromic forms of diabetes (except PWS and BSS) more than 50 % of patients had positive beta-cell antibodies. Recently, a report was published on positive beta-cell antibodies in German and Austrian patients with non-autoimmune T2DM [ 40 ] . 811 of 2 291 American patients with diabetes were classifi ed as insulin-resistant (IR) in the SEARCH for Diabetes in Youth study. However, the proportion of IR was signifi cantly lower in youths with autoimmune diabetes (26.3 vs. 61.1 %, p < 0.0001). The investigators and clinicians described the group of patients with autoimmune diabetes plus IR as having diabetes of mixed aetiology ("hybrid" diabetes) [ 41 ] . 10 of 1 248 insulin sensitive and 34 of 446 insulin resistant patients with positive beta-cell antibodies were clinically described as T2DM [ 41 ] . The positive beta-cell antibodies in our patients with syndromic types of diabetes may be explained by a mixed aetiology. The presence of beta-cell antibodies suggests an autoimmune aetiology in some patients with syndromic diabetes, beta-cell antibodies being most frequent in TS and DS (80.8 % of patients with DS and 78 % of patients with TS had positive beta-cell antibodies) and rare in other syndromes such as PWS or KS.
Other autoimmune phenomena associated with syndromic forms of diabetes were also predominantly found in DS and TS: 45.7 % of DS patients and 46 % of TS patients had thyroid antibodies, and 42.4 % of DS patients and 17 % of TS patients had coeliac disease antibodies. The increased risk of coeliac disease and hypothyroidism has been reported previously [ 1 ] . By comparison, 107 Danish TS patients with a median age of 36.7 (range 6-60) years were screened for diff erent autoimmune antibodies and found to have coeliac disease antibodies (18 % of patients), antibodies against adrenal cortex (1 %), antibodies against thyroid peroxidase (45 %) and GAD 65 antibodies (4 %) [ 42 ] . In Taiwan thyroid autoantibodies were detected in 27 % of children with TS [ 43 ] . Out of 45 girls with TS screened for endomysium antibodies and IgA tissue transglutaminase antibodies in British Columbia, Canada, 8 (17.8 %) had positive antibodies (1 had both antibodies and 7 had only transglutaminase antibodies) [ 44 ] . The diff erences in GAD antibody distribution noted between the Danish and German/Austrian patients may be due to diff erences in study design. Whereas the Danish study reported the rate of GAD antibodies in all TS patients [ 42 ] , our study documented the rate of GAD antibodies in diabetic TS patients. The diff erent results for thyroid autoantibodies in Taiwan compared with our study could be due to ethnic factors. The other positive autoimmune markers were also found in our patients, similar to the Danish and Canadian studies mentioned above. Interestingly, the comparison of TS patients with and without GH therapy showed no statistically signifi cant diff erences in HbA 1c , BMI-SDS or incidence of dyslipidaemia in those treated with GH. Microalbuminuria was detected more frequently in the GH-treated group. All GH-treated patients received insulin treatment, whereas only 44 % of the patients without GH replacement were given insulin. Improved metabolic control therefore might be due to insulin therapy. Theoretically, GH treatment might boost insulin resistance. However, Wooten and colleagues found fasting glucose levels and insulin concentrations to be similar in TS patients with and without GH replacement [ 45 ] . However, 28 % of the patients not treated with GH showed impaired glucose tolerance as compared with 7 % of GH-treated patients [ 45 ] .
In conclusion, with this study of diabetes in genetic syndromes, we hope to draw attention to these rare disorders. Among the genetic syndromes in which diabetes frequently develops, DS [ 1 ] and TS are the most frequent. The results for diabetes-specifi c antibodies indicate that the pathogenesis of diabetes appears to vary considerably both within and across the syndromic disorders. Treatment with insulin and/or oral antidiabetic drugs is carried out very individually, adapted to the particular syndrome, with the suspected pathogenetic mechanism of diabetes potentially contributing to therapeutic decisions.
